MORGAN STANLEY - INTEGRA LIFESCIENCES HLDGS C ownership

INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 273 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of INTEGRA LIFESCIENCES HLDGS C
ValueSharesWeighting
Q3 2023$227,178,709
-11.7%
5,948,642
-4.9%
0.02%
-8.0%
Q2 2023$257,309,499
-31.8%
6,256,003
-4.8%
0.02%
-37.5%
Q1 2023$377,356,599
+6.9%
6,573,010
+4.4%
0.04%0.0%
Q4 2022$353,059,651
+801.9%
6,296,765
+581.3%
0.04%
+700.0%
Q3 2022$39,147,000
-18.0%
924,163
+4.6%
0.01%
-16.7%
Q2 2022$47,754,000
+2.9%
883,835
+22.4%
0.01%0.0%
Q1 2022$46,411,000
+5.3%
722,223
+9.8%
0.01%
+20.0%
Q4 2021$44,073,000
-12.3%
657,908
-10.4%
0.01%
-28.6%
Q3 2021$50,254,000
+38.9%
733,868
+38.5%
0.01%
+40.0%
Q2 2021$36,169,000
+14.6%
530,044
+16.1%
0.01%0.0%
Q1 2021$31,556,000
+2.4%
456,727
-3.8%
0.01%0.0%
Q4 2020$30,826,000
+65.1%
474,829
+20.1%
0.01%
+25.0%
Q3 2020$18,674,000
+3.6%
395,493
+3.1%
0.00%0.0%
Q2 2020$18,017,000
+7.0%
383,433
+1.8%
0.00%
-20.0%
Q1 2020$16,831,000
+132.2%
376,781
+202.9%
0.01%
+150.0%
Q4 2019$7,250,000
+16.4%
124,400
+20.0%
0.00%0.0%
Q3 2019$6,229,000
+308.7%
103,702
+279.8%
0.00%
Q2 2019$1,524,000
-14.4%
27,302
-14.5%
0.00%
-100.0%
Q1 2019$1,780,000
-82.6%
31,946
-85.9%
0.00%
-66.7%
Q4 2018$10,227,000
+65.1%
226,777
+141.2%
0.00%
+50.0%
Q3 2018$6,193,000
-38.8%
94,024
-40.1%
0.00%
-33.3%
Q2 2018$10,116,000
+10.3%
157,035
-5.3%
0.00%0.0%
Q1 2018$9,174,000
+19.3%
165,777
+3.2%
0.00%
+50.0%
Q4 2017$7,689,000
+37.5%
160,654
+45.0%
0.00%0.0%
Q3 2017$5,592,000
+29.5%
110,788
+39.8%
0.00%
+100.0%
Q2 2017$4,318,000
-85.1%
79,227
-88.5%
0.00%
-75.0%
Q1 2017$29,026,000
+68.6%
688,996
+243.3%
0.00%
+33.3%
Q4 2016$17,214,000
+132.5%
200,672
+123.7%
0.00%0.0%
Q3 2016$7,405,000
+394.7%
89,707
+377.6%
0.00%
+200.0%
Q2 2016$1,497,000
-74.7%
18,784
-78.6%
0.00%
-50.0%
Q1 2016$5,920,000
+384.1%
87,887
+387.0%
0.00%
Q4 2015$1,223,000
+45.9%
18,046
+28.2%
0.00%
Q3 2015$838,000
-66.4%
14,076
-62.0%
0.00%
-100.0%
Q2 2015$2,494,000
+88.4%
37,007
+72.3%
0.00%
Q1 2015$1,324,000
+9.3%
21,474
-3.9%
0.00%
Q4 2014$1,211,000
+35.3%
22,339
+23.9%
0.00%
Q3 2014$895,000
-15.0%
18,036
-19.4%
0.00%
Q2 2014$1,053,000
-13.7%
22,368
-15.6%
0.00%
-100.0%
Q1 2014$1,220,000
+165.8%
26,497
+175.6%
0.00%
Q4 2013$459,000
+8.0%
9,613
-9.0%
0.00%
Q3 2013$425,000
-14.7%
10,562
-22.3%
0.00%
Q2 2013$498,00013,5880.00%
Other shareholders
INTEGRA LIFESCIENCES HLDGS C shareholders Q1 2022
NameSharesValueWeighting ↓
Champlain Investment Partners, LLC 5,473,820$305,001,0002.66%
FALCON POINT CAPITAL, LLC 80,729$4,498,0002.45%
Tributary Capital Management, LLC 508,838$28,352,0002.06%
Broadfin Capital, LLC 141,572$7,888,0001.63%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 182,585$10,174,0001.57%
Sapience Investments, LLC 132,810$7,400,0000.98%
VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. 1,110,177$61,860,0000.83%
Bellevue Group AG 222,350$12,389,0000.68%
Capital International Sarl 74,325$4,141,0000.52%
Hood River Capital Management LLC 180,772$10,073,0000.51%
View complete list of INTEGRA LIFESCIENCES HLDGS C shareholders